Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer

News   Jul 24, 2012

 
Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer
 
 
 

RELATED ARTICLES

Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the Body

News

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.

READ MORE

3D Metabolic Map is Computational First

News

The computer model integrates over 4,000 metabolites and 13,000 proteins.

READ MORE

HIV Saliva Test Adapted for Rapid Zika Diagnosis

News

Researchers are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE